$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release formulation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/30
출원번호 US-0078505 (1987-07-28)
발명자 / 주소
  • Howard John R. (Merseyside GBX) Timmins Peter (Merseyside GBX)
출원인 / 주소
  • E. R. Squibb & Sons, Inc. (Princeton NJ 02)
인용정보 피인용 횟수 : 109  인용 특허 : 1

초록

A controlled release pharmaceutical formulation is provided which releases a pharmaceutical of a basic character at a controlled rate regardless of the pH of the environment, which formulation includes a basic pharmaceutical, up to about 45% by weight of a pH dependent polymer which is a salt of alg

대표청구항

A controlled release pharmaceutical formulation from which a pharmaceutical of a basic character is released at a controlled rate irrespective of the pH of the environment, consisting essentially of a pharmaceutical of a basic character, a pH-dependent polymer which is a salt of alginic acid, in an

이 특허에 인용된 특허 (1)

  1. Jain Nemichand B. (Monmouth Junction NJ) Gertie Linda P. (Cinnaminson NJ) Rudnic Edward M. (Plainsboro NJ), Controlled release formulation.

이 특허를 인용한 특허 (109)

  1. Kositprapa, Unchalee; Sriwongjanya, Mongkol, Antihistamine and decongestant system.
  2. Blättler, Walter Anton; Romão, Carlos J. R. C.; Rodrigues, Sandra Sofia Pereira; Kromer, Lukas Adrian; Otterbein, Leo Edmond; Gallo, David John, Carbon monoxide releasing molecules and uses thereof.
  3. Albert,Kenneth Stephen; Maes,Paul Jos챕, Chronotherapeutic diltiazem formulations and the administration thereof.
  4. Geoghegan Edward J. (Athlone IEX) Mulligan Seamus (Gainesville GA) Panoz Donald E. (Tuckerstown BMX), Controlled absorption diltiazen formulation for once-daily administration.
  5. Nagaprasad Vishnubhotla,INX ; Sen Himadri,INX, Controlled drug delivery system for diltiazem.
  6. Fassihi Reza ; Yang Libo, Controlled release drug delivery system.
  7. Baichwal Anand (Wappingers Falls NY) McCall Troy W. (New Milford CT), Controlled release formulation (albuterol).
  8. Baichwal Anand ; McCall Troy W., Controlled release formulation (albuterol).
  9. Chen,Chih Ming; Cheng,Xiu Xiu, Controlled release oral dosage form of beta-adrenergic blocking agents.
  10. Rubinstein, Abraham; Radai, Raphael; Friedman, Michael; Tirosh, Boaz; Baluom, Muhammad; Nassar, Taher, Controlled release oral drug delivery system.
  11. Gombotz Wayne R. ; Wee SiowFong, Controlled release polypeptide compositions and methods of treating inflammatory bowel disease.
  12. Pearnchob, Nantharat; Friedl, Thomas; Wagner, Karl Gerhard; Sommer, Florian, Controlled release system and method for manufacturing the same.
  13. Kim Cherng-ju, Controlled release tablet.
  14. Åslund, Bengt Leonard; Bengtsson, Stefan; Bergman, Gudrun Anita; Hohlneicher, Ursula Renata Maria; Ymén, Bo Ingvar, Crystalline forms.
  15. Orsoni, Sandrine; Willcox, Nathalie, Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide.
  16. Orsoni-Segona, Sandrine; Willcox, Nathalie, Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide.
  17. Chen, Chih-Ming; Cheng, Xiu Xiu; Jan, Steve, Diltiazem controlled release formulation and method of manufacture.
  18. Doty Brian D. (Phoenixville PA) Meyer Mark (Ames IA), Dried animal plasma as a pharmaceutical excipient for compressed tablet formulation.
  19. Michael Augello ; Sheila M. Dell ; Eric H. Bliefernich, Edible MCC/PGA coating composition.
  20. Augello, Michael, Edible PGA coating composition.
  21. Augello, Michael; Bliefernich, Eric, Edible PGA coating composition.
  22. Augello, Michael; Dell, Sheila M.; Tuason, Domingo C.; Modliszewski, James J.; Ruszkay, Thomas A.; Werner, David E., Edible coating composition.
  23. Michael Augello ; Sheila M. Dell ; Domingo C. Tuason ; James J. Modliszewski ; Thomas A. Ruszkay ; David E. Werner, Edible coating composition.
  24. Eisenreich, Wolfram; Friedl, Thomas, Extended release tablet formulations of flibanserin and method for manufacturing the same.
  25. Eisenreich, Wolfram; Friedl, Thomas; Sommer, Florian; Pearnchob, Nantharat; Wagner, Karl G., Extended release tablet formulations of flibanserin and method for manufacturing the same.
  26. Castro, Ramiro; Ceci, Angelo, Flibanserin for the treatment of urinary incontinence and related diseases.
  27. Castro, Ramiro; Ceci, Angelo, Flibanserin for the treatment of urinary incontinence and related diseases.
  28. Sriwongjanya,Mongkol; Yuk,Samuel; Nangia,Avinash, Formulation and process for drug loaded cores.
  29. Orsoni, Sandrine; Willcox, Nathalie, Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt.
  30. Orsoni, Sandrine; Willcox, Nathalie, Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt.
  31. Orsoni, Sandrine; Willcox, Nathalie, Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt.
  32. Ridoux Claude (Isle-sur-Sorgue FRX), Granulated compositions of polysaccharides, process for their preparation and use.
  33. Karetny Marc S. ; Erkoboni David F. ; Vladyka ; Jr. Ronald S. ; Stamato Howard J., Hydrolyzed cellulose granulations for pharmaceuticals.
  34. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  35. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  36. Inghardt, Tord, Mandelic acid derivatives and their use as thrombin inhibitors.
  37. Inghardt, Tord, Mandelic acid derivatives and their use as thrombin inhibitors.
  38. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  39. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  40. Haas, Werner E.; Romao, Carlos C.; Royo, Beatriz; Fernandes, Ana Cristina; Goncalves, Isabel, Method for treating a mammal by administration of a compound having the ability to release CO.
  41. Bowersock,Terry L.; Guimond,Paul; Ju,Tzu Chi R.; Kidane,Argaw, Method of vaccinating vertebrates.
  42. Chow, San-Laung; Wong, David; Garcia, Damian, Methods and formulations for making pharmaceutical compositions containing bupropion.
  43. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  44. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  45. Singh, Bramah N., Methods of treatment using sustained release sotalol forumalations.
  46. Magnusson, Anders; Thune, Mikael, Modified release pharmaceutical formulation.
  47. Magnusson,Anders; Thune,Mikael, Modified release pharmaceutical formulation.
  48. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  49. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  50. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  51. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  52. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  53. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  54. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  55. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  56. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  57. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified release preparations containing oxcarbazepine and derivatives thereof.
  58. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  59. Bhatt, Padmanabh P.; Kidane, Argaw; Edwards, Kevin, Modified-release preparations containing oxcarbazepine and derivatives thereof.
  60. Costantini, Dominique; Lemarchand, Caroline, Mucosal bioadhesive slow release carrier for delivering active principles.
  61. Costantini, Dominique; Lemarchand, Caroline, Mucosal bioadhesive slow release carrier for delivering active principles.
  62. Zerbe, Horst G.; Paiement, Nadine; Lspas-Szabo, Pompilia, Multilayer tablet.
  63. Dennis Andrew B.,GBX ; Timmins Peter,GBX ; Hodsdon Alison C.,GBX, Nefazodone dosage form.
  64. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  65. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  66. Sriwongjanya,Mongkol; Weng,Timothy; Barman,David; Kositprapa,Unchalee, Once a day antihistamine and decongestant formulation.
  67. Bhagwat Dileep ; Diehl ; II Donald ; Baichwal Anand R., Once-a-day controlled release sulfonylurea formulation.
  68. Bhagwat, Dileep; Baichwal, Anand R.; Diehl, II, Donald, Once-a-day controlled release sulfonylurea formulation.
  69. Bhagwat, Dileep; Diehl, II, Donald; Baichwal, Anand R., Once-a-day controlled release sulfonylurea formulation.
  70. Talwar, Naresh; Sen, Himadri; Staniforth, John N., Orally administered drug delivery system providing temporal and spatial control.
  71. Nomura, Masafumi; Nishiyama, Tetsuyuki; Ichikawa, Mari; Fukaya, Kyoko, Peroral tablet for bowel cleansing.
  72. Gaik-Lim Khoo, Cynthia; Gustafsson, Helena, Pharmaceutical formulation.
  73. Monteith, David; O'Mullane, John; Reo, Joseph P.; Nowak, Robert T.; Wan, Jiansheng; Kabir, Mohammed A.; Abutarif, Malaz A.; Fritz, Glenn E., Phenylephrine pharmaceutical formulations and compositions for colonic absorption.
  74. Jain Girish Kumar,INX ; Rampal Ashok,INX ; Sen Himadri,INX, Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine.
  75. Aiache, Jean-Marc; Costantini, Dominique; Chaumont, Christine, Prolonged release bioadhesive therapeutic systems.
  76. Pamplona, Ana; Bernardes, Gonçalo J. L.; Mota, Maria M.; Romão, Carlos C., Ruthenium carbon monoxide releasing molecules and uses thereof.
  77. Pamplona, Ana; Bernardes, Gonçalo J. L.; Mota, Maria M.; Romão, Carlos C., Ruthenium carbon monoxide releasing molecules and uses thereof.
  78. Ahlqvist, Matti; Bohlin, Martin; Inghardt, Tord; Lundblad, Anita; Sigfridsson, Carl-Gustaf, Salts.
  79. Ahlqvist,Matti; Bohlin,Martin; Inghardt,Tord; Lundblad,Anita; Sigfridsson,Carl Gustaf, Salts.
  80. Zerbe, Horst; Paiement, Nadine; Angusti, Angela; Long, Cormac, Solid oral film dosage forms and methods for making same.
  81. Bombarda,Carlo; Dubini,Enrica; Ezhaya,Antoine; Schneider, legal representative,Margarete; Schneider,Heinrich, Stable polymorph of flibanserin.
  82. Woo, Jong-Soo; Chi, Moon-Hyuk, Sustained release composition for oral administration of drugs.
  83. Pilgaonkar, Pratibha S.; Rustomjee, Maharukh T.; Gandhi, Anilkumar S.; Jain, Paras R.; Kelkar, Atul A., Sustained release dosage form.
  84. Pilgaonkar, Pratibha S; Rustomjee, Maharukh T; Gandhi, Anilkumar S; Jain, Paras R; Kelkar, Atul A, Sustained release dosage form.
  85. Baichwal Anand R., Sustained release excipient.
  86. Guohua Zhang ; Prasad Pinnamaraju ; Muhammad Ali, Sustained release formulation containing three different types of polymers and tablet formed therefrom.
  87. Zhang Guohua ; Pinnamaraju Prasad ; Ali Muhammad, Sustained release formulation containing three different types of polymers and tablet formed therefrom.
  88. Khan Sadath U. (Mine Hill NJ) Phillips Reginald (Coral Springs FL), Sustained release formulations.
  89. Singh, Bramah N., Sustained release formulations of sotalol.
  90. Baichwal Anand R., Sustained release heterodisperse hydrogel systems for insoluble drugs.
  91. Baichwal Anand R. (Wappingers Falls NY), Sustained release heterodisperse hydrogel systems for insoluble drugs.
  92. Baichwal Anand R. (Wappingers Falls NY), Sustained release heterodisperse hydrogel systems for insoluble drugs.
  93. Baichwal, Anand R., Sustained release heterodisperse hydrogel systems for insoluble drugs.
  94. Baichwal Anand, Sustained release heterodisperse hydrogel systems--amorphous drugs.
  95. Baichwal Anand, Sustained release heterodisperse hydrogel systems-amorphous drugs.
  96. Baichwal Anand, Sustained release heterodisperse hydrogel systems-amorphous drugs.
  97. Baichwal Anand R., Sustained release matrix for high-dose insoluble drugs.
  98. Baichwal Anand R., Sustained release matrix for high-dose insoluble drugs.
  99. Baichwal, Anand R., Sustained release matrix for high-dose insoluble drugs.
  100. Baichwal, Anand R.; McCall, Troy W.; Liu, Lirong; Labudzinski, Steve, Sustained release matrix systems for highly soluble drugs.
  101. Nirmal Mulye ; Kavita Inamdar IN, Sustained release tablet containing hydrocolloid and cellulose ether.
  102. Penhasi, Adel; Gomberg, Mila, Sustained-release donepezil formulation.
  103. Kerc Janez,SIX ; Rebic Ljubomira Barbara,SIX ; Kofler Bojan,SIX, Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application.
  104. Borsini, Franco; Evans, Kenneth Robert, Treating sexual desire disorders with flibanserin.
  105. Borsini, Franco; Evans, Kenneth Robert, Treating sexual desire disorders with flibanserin.
  106. Hanes, Vladimir; Verbeek, Anna Elizabeth, Treatment of vasomotor symptoms.
  107. Ceci, Angelo; Schindler, Marcus, Use of flibanserin in the treatment of obesity.
  108. Ceci, Angelo; Schindler, Marcus, Use of flibanserin in the treatment of obesity.
  109. Zhang Guohua ; Pinnamaraju Prasad ; Ali Muhammad A., Water insoluble polymer based sustained release formulation.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로